Abstract
Osteoporosis becomes common with aging in both sexes, but is often ignored in men. The 2013 International Society for Clinical Densitometry consensus conference endorsed a Caucasian female referent database for T-score calculation in men. This recommendation has generated controversy and concern. Accumulating data indicate that at the same DXA-measured body mineral density (BMD) (g/cm2), men and women are at approximately the same fracture risk. With this point in mind, using the same database to derive the T-score in men and women is reasonable. As a result, a greater proportion of men who sustain a fragility fracture will have T-scores that are higher than they would if a male database were used; in fact, many men will fracture at T-scores that are “normal.” This highlights the importance of diagnosing osteoporosis not just by T-score, but also by the presence of fragility fracture and/or by estimations of fracture risk as generated by tools such as the FRAX calculator. The practical consequences of this change in densitometric definition of osteoporosis in men should be monitored, including the proportion of men at risk identified and treated as well as defining the response to treatment in those assessed by this more comprehensive approach.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Anonymous. Osteoporosis prevention, diagnosis and therapy NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA. 2001;285:785–95.
Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992;3:224–9.
Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301:513–21.
Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:1802–22.
Amin S, Achenbach SJ, Atkinson EJ, et al. Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res. 2014;29:581–9.
Cooper C, Cole ZA, Holroyd CR, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22:1277–88.
Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465–75.
Watts NB. Osteoporosis in men. Endocr Pract. 2013;19:834–8.
Orwoll ES, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604–10.
Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med. 2012;367:1714–23. This is the first therapeutic study in men with fracture as the primary outcome. Zoledronic acid reduced morphometric vertebral fractures in men, compared with placebo.
Solomon DH, Johnston SS, Boytsov NN, et al. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res. 2014;29(9):1929-1937
Watts NB, Leslie WD, Foldes AJ, et al. 2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases. J Clin Densitom. 2013;16:472–81.
Faulkner KG. The tale of the T-score: review and perspective. Osteoporos Int. 2005;16:347–52.
Anonymous. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis WHO Technical Report Series 843. World Health Organization. 1994.
Watts NB. Using bone mineral density T-scores to diagnose postmenopausal osteoporosis. Endocr Pract. 2000;6:217–8.
Faulkner KG, Roberts LA, McClung MR. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int. 1996;6:432–6.
Steiger P. Letter to the editor standardization of spine BMD measurements. J Bone Miner Res. 1995;10:1602–3.
Hanson J. Letter to the editor; standardization of femur BMD. J Bone Miner Res. 1997;8:1316–7.
Binkley N, Schmeer P, Wasnich RD, et al. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom. 2002;5(Suppl):S19–27.
Kanis JA, Bianchi G, Bilezikian JP, et al. Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int. 2011;22:2789–98.
Hans PDD, Downs RW, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:15–21.
Ross PD, Lombardi A, Freedholm D. The assessment of bone mass in men. In: Orwoll ES, editor. Osteoporosis in men: The effects of gender on skeletal health. San Diego: Academic Press; 1999. p. 505–25.
De Laet CEDH, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13:1587–93.
Cheng S, Suominen H, Sakari-Rantala R, et al. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res. 1997;12:1075–82.
De Laet CE, van Hout BA, Burger H, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J. 1997;315:221–5.
The EuropeanProspective Osteoporosis Study (EPOS) Group Authors. The relationship between bone density and incident vertebral fracture in men and women. J Bone Miner Res. 2002;17:2214–21.
Langsetmo L, Leslie WD, Zhou W, et al. Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. J Bone Miner Res. 2010;25:2108–14.
Leslie WD, Langsetmo L, Zhou W, et al. Choice of lumbar spine bone density reference database for fracture prediction in men and women: a population-based analysis. J Clin Densitom. 2014;17:295–300.
Selby PL, Davies M, Adams JE. Do men and women fracture bones at similar bone densities? Osteoporos Int. 2000;11:153–7.
Cauley JA, Zmuda JM, Wisniewski SR, et al. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2004;15:32–7.
Riggs BL, Melton LJI, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res. 2004;19:1945–54.
Gilsanz V, Boechat MI, Gilsanz R, et al. Gender differences in vertebral sizes in adults: biomechanical implications. Radiology. 1994;190:678–82.
Looker AC, Beck TJ, Orwoll ES. Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res. 2001;16:1291–9.
Srinivasan B, Kopperdahl DL, Amin S, et al. Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women. Osteoporos Int. 2012;23:155–62. This study provided information on bone strength, supporting the concept that men and women fracture at approximately the same absolute bone mineral density as measured by DXA.
Pasco JA, Lane SE, Brennan SL, et al. Fracture risk among older men: osteopenia and osteoporosis defined using cut-points derived from female versus male reference data. Osteoporos Int. 2014;25:857–62. In this study, men who had osteoporotic fractures were likely to have normal bone density by DXA if a female normative database was used for T-score calculation, illustrating a potential practical problem.
Wiemann L, Krueger D, Vallarta-Ast N, et al. Effect of female database use for T-score derivation in men. J Clin Densitom. 2006;10:244–8.
Schousboe JT, Tanner SB, Leslie WD. Definition of osteoporosis by bone density criteria in men: effect of using female instead of male young reference data depends on skeletal site and densitometer manufacturer. J Clin Densitom. 2014;17:301–6. This is a review of the rationale for using a Caucasian female normative database for determining the DXA T-score in men.
Siris ES, Boonen S, Mitchell PJ, et al. What's in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int. 2012;23:2093–7.
Siris ES, Adler R, Bilezikian J, et al. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 2014;25:1439–43. This paper provides the rationale for making the diagnosis of osteoporosis in patients who may not have a DXA T-score ≤ -2.5.
Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J. 2010;182:1864–73.
Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update; 2013. Maturitas. 2013;75:392–6.
Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.
Kanis JA, Adams J, Borgstrom F, et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone. 2008;42:4–15.
Adler RA. Osteoporosis in men: recent progress. Endocrine. 2013;44:40–6.
Smith MR, Egerdie B, Hernandez Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009;361:745–55.
Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci. 2014;69:547–58.
Di Monaco M, Castiglione C, Vallero F, et al. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr. 2012;55:e48–52.
Buehring B, Binkley N. Myostatin—the holy grail for muscle, bone, and fat? Curr Osteoporos Rep. 2013;11:407–14.
Compliance with Ethics Guidelines
Conflict of Interest
N. Binkley has received consultancy fees or funding from Merck Sharp & Dohme, Lilly, and Amgen.
R. Adler and J. P. Bilezikian declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
All studies by the authors involving animal and/or human subjects were performed after approval by the appropriate institutional review boards. When required, written informed consent was obtained from all participants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Binkley, N., Adler, R. & Bilezikian, J.P. Osteoporosis Diagnosis in Men: The T-Score Controversy Revisited. Curr Osteoporos Rep 12, 403–409 (2014). https://doi.org/10.1007/s11914-014-0242-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-014-0242-z